207 related articles for article (PubMed ID: 30357927)
1. Urinary proteomics to diagnose chronic active antibody-mediated rejection in pediatric kidney transplantation - a pilot study.
Kanzelmeyer NK; Zürbig P; Mischak H; Metzger J; Fichtner A; Ruszai KH; Seemann T; Hansen M; Wygoda S; Krupka K; Tönshoff B; Melk A; Pape L
Transpl Int; 2019 Jan; 32(1):28-37. PubMed ID: 30357927
[TBL] [Abstract][Full Text] [Related]
2. Refinement of the criteria for ultrastructural peritubular capillary basement membrane multilayering in the diagnosis of chronic active/acute antibody-mediated rejection.
Go H; Shin S; Kim YH; Han DJ; Cho YM
Transpl Int; 2017 Apr; 30(4):398-409. PubMed ID: 28109026
[TBL] [Abstract][Full Text] [Related]
3. Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection.
Rabant M; Amrouche L; Lebreton X; Aulagnon F; Benon A; Sauvaget V; Bonifay R; Morin L; Scemla A; Delville M; Martinez F; Timsit MO; Duong Van Huyen JP; Legendre C; Terzi F; Anglicheau D
J Am Soc Nephrol; 2015 Nov; 26(11):2840-51. PubMed ID: 25948873
[TBL] [Abstract][Full Text] [Related]
4. Urinary Metabolomics for Noninvasive Detection of Antibody-Mediated Rejection in Children After Kidney Transplantation.
Blydt-Hansen TD; Sharma A; Gibson IW; Wishart DS; Mandal R; Ho J; Nickerson P; Rush D
Transplantation; 2017 Oct; 101(10):2553-2561. PubMed ID: 28121909
[TBL] [Abstract][Full Text] [Related]
5. Mining the human urine proteome for monitoring renal transplant injury.
Sigdel TK; Gao Y; He J; Wang A; Nicora CD; Fillmore TL; Shi T; Webb-Robertson BJ; Smith RD; Qian WJ; Salvatierra O; Camp DG; Sarwal MM
Kidney Int; 2016 Jun; 89(6):1244-52. PubMed ID: 27165815
[TBL] [Abstract][Full Text] [Related]
6. Characterization of renal allograft rejection by urinary proteomic analysis.
Clarke W; Silverman BC; Zhang Z; Chan DW; Klein AS; Molmenti EP
Ann Surg; 2003 May; 237(5):660-4; discussion 664-5. PubMed ID: 12724632
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Bone Marrow-Derived Mesenchymal Stem Cells for Chronic Antibody-Mediated Rejection After Kidney Transplantation- A Single-Arm, Two-Dosing-Regimen, Phase I/II Study.
Wei Y; Chen X; Zhang H; Su Q; Peng Y; Fu Q; Li J; Gao Y; Li X; Yang S; Ye Q; Huang H; Deng R; Li G; Xu B; Wu C; Wang J; Zhang X; Su X; Liu L; Xiang AP; Wang C
Front Immunol; 2021; 12():662441. PubMed ID: 34248942
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive differentiation of non-rejection kidney injury from acute rejection in pediatric renal transplant recipients.
Archdekin B; Sharma A; Gibson IW; Rush D; Wishart DS; Blydt-Hansen TD
Pediatr Transplant; 2019 May; 23(3):e13364. PubMed ID: 30719822
[TBL] [Abstract][Full Text] [Related]
9. Single-Cell Transcriptome Analysis of Chronic Antibody-Mediated Rejection After Renal Transplantation.
Kong F; Ye S; Zhong Z; Zhou X; Zhou W; Liu Z; Lan J; Xiong Y; Ye Q
Front Immunol; 2021; 12():767618. PubMed ID: 35111153
[TBL] [Abstract][Full Text] [Related]
10. Association of the chronic kidney disease urinary proteomic predictor CKD273 with clinical risk factors of graft failure in kidney allograft recipients.
Rambabova-Bushljetik I; Metzger J; Siwy J; Dohcev S; Bushljetikj O; Filipce V; Trajceska L; Mischak H; Spasovski G
Nephrol Dial Transplant; 2022 Sep; 37(10):2014-2021. PubMed ID: 34634117
[TBL] [Abstract][Full Text] [Related]
11. Pre-existing donor-specific antibodies are detrimental to kidney allograft only when persistent after transplantation.
Caillard S; Becmeur C; Gautier-Vargas G; Olagne J; Muller C; Cognard N; Perrin P; Braun L; Heibel F; Lefebre F; Renner V; Gachet C; Moulin B; Parissiadis A
Transpl Int; 2017 Jan; 30(1):29-40. PubMed ID: 27678382
[TBL] [Abstract][Full Text] [Related]
12. A Noninvasive Urine Metabolome Panel as Potential Biomarkers for Diagnosis of T Cell-Mediated Renal Transplant Rejection.
Kalantari S; Chashmniam S; Nafar M; Samavat S; Rezaie D; Dalili N
OMICS; 2020 Mar; 24(3):140-147. PubMed ID: 32176594
[TBL] [Abstract][Full Text] [Related]
13. Living-donor kidney transplantation with existing anti-donor specific antibodies at a Japanese single center.
Ushigome H; Harada S; Nakao M; Nakamura T; Koshino K; Suzuki T; Ito T; Nobori S; Yoshimura N
Transplant Proc; 2015 Apr; 47(3):612-6. PubMed ID: 25891696
[TBL] [Abstract][Full Text] [Related]
14. Early graft function defined by area under the curve serum creatinine 7 days post-transplant in a series of live donor kidney transplantation.
Hosgood SA; Barlow AD; Johari Y; Bankart MJ; Nicholson ML
J Surg Res; 2011 Dec; 171(2):838-43. PubMed ID: 20828760
[TBL] [Abstract][Full Text] [Related]
15. Association of C1q-fixing DSA with late graft failure in pediatric renal transplant recipients.
Fichtner A; Süsal C; Höcker B; Rieger S; Waldherr R; Westhoff JH; Sander A; Opelz G; Tönshoff B
Pediatr Nephrol; 2016 Jul; 31(7):1157-66. PubMed ID: 26928311
[TBL] [Abstract][Full Text] [Related]
16. Urine protein profiling identified alpha-1-microglobulin and haptoglobin as biomarkers for early diagnosis of acute allograft rejection following kidney transplantation.
Stubendorff B; Finke S; Walter M; Kniemeyer O; von Eggeling F; Gruschwitz T; Steiner T; Ott U; Wolf G; Wunderlich H; Junker K
World J Urol; 2014 Dec; 32(6):1619-24. PubMed ID: 24549629
[TBL] [Abstract][Full Text] [Related]
17. Minimum mycophenolic acid levels are associated with donor-specific antibody formation.
Filler G; Todorova EK; Bax K; Alvarez-Elías AC; Huang SH; Kobrzynski MC
Pediatr Transplant; 2016 Feb; 20(1):34-8. PubMed ID: 26589470
[TBL] [Abstract][Full Text] [Related]
18. Development and nationwide validation of kidney graft injury markers using urinary exosomes and microvesicles (complete English translation of the Japanese version).
Harada H; Fukuzawa N; Abe T; Imamura R; Masaki N; Fujiyama N; Sato S; Hatakeyama S; Nishimura K; Kishikawa H; Iwami D; Hotta K; Miura M; Ide K; Nakamura M; Kosoku A; Uchida J; Murakami T; Tsuji T
BMC Nephrol; 2023 Jun; 24(1):158. PubMed ID: 37280521
[TBL] [Abstract][Full Text] [Related]
19. Serum Aberrant N-Glycan Profile as a Marker Associated with Early Antibody-Mediated Rejection in Patients Receiving a Living Donor Kidney Transplant.
Noro D; Yoneyama T; Hatakeyama S; Tobisawa Y; Mori K; Hashimoto Y; Koie T; Tanaka M; Nishimura SI; Sasaki H; Saito M; Harada H; Chikaraishi T; Ishida H; Tanabe K; Satoh S; Ohyama C
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28786963
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of de novo donor-specific antibody in kidney transplant recipients with chronic antibody-mediated rejection.
Park WY; Kim Y; Paek JH; Jin K; Han S
Korean J Transplant; 2021 Mar; 35(1):33-40. PubMed ID: 35769616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
